Reading view

There are new articles available, click to refresh the page.

National Democrats target US Senate GOP incumbents on health care votes

U.S. Senate Appropriations Committee Chairwoman Susan Collins, R-Maine, speaks with reporters inside the Capitol building in Washington, D.C., on Monday, Sept. 29, 2025. (Photo by Jennifer Shutt/States Newsroom)

U.S. Senate Appropriations Committee Chairwoman Susan Collins, R-Maine, speaks with reporters inside the Capitol building in Washington, D.C., on Monday, Sept. 29, 2025. (Photo by Jennifer Shutt/States Newsroom)

The Democratic National Committee will run ads Thursday on the home pages of newspapers in a quartet of Republican senators’ hometowns, calling on the incumbents up for reelection next year to support a Democratic bill to extend health care subsidies.

The digital ads target Sens. Dan Sullivan of Alaska, Susan Collins of Maine, Jon Husted of Ohio and John Cornyn of Texas on the day the Senate is expected to vote on a Democratic proposal to extend enhanced subsidies for insurance purchased on the Affordable Care Act marketplace. 

Without the extension, premiums are projected to sharply rise next year.

“REPUBLICAN ARE DOUBLING HEALTH CARE COSTS,” one mockup of the ad provided to States Newsroom reads. “Tell Senator Collins we can’t afford their price hike.”

The ads running in states with two GOP senators also mention the one not on the ballot next year: Sens. Lisa Murkowski of Alaska, Bernie Moreno of Ohio and Ted Cruz of Texas.

“Today’s Senate vote to extend the ACA tax credits could be the difference between life and death for many Americans,” DNC Chair Ken Martin said in a press release. “Over 20 million Americans will see their health care premiums skyrocket next year if Susan Collins, John Cornyn, Jon Husted, and Dan Sullivan do not stand with working families and vote to extend these lifesaving credits.”

‘Affordability’ on the ballot

Democrats have sought to make health care costs a major issue as both parties have projected a focus on affordability issues in next year’s midterm elections that will determine control of Congress.

Senate Democrats initiated a six-week government shutdown this year in an effort to force Republicans to negotiate on the expiring subsidies, which Congress expanded during the COVID-19 pandemic.

Senate Majority Leader John Thune, R-S.D., promised a vote on a bill to address rising premiums in exchange for ending the shutdown.

The chamber will vote Thursday on a Democratic proposal that would extend the enhanced ACA marketplace tax credits for three years.

Senators will also vote Thursday on legislation from Republicans Bill Cassidy of Louisiana and Mike Crapo of Idaho that would provide up to $1,500 annually for people who buy either bronze or catastrophic health insurance plans from the ACA marketplace.

House Speaker Mike Johnson, R-La., said Wednesday that chamber would vote next week on an unspecified measure to address the expiring tax credits.

President Donald Trump said Wednesday that Republicans’ goal was to provide funding “directly to the people” to “buy their own health care.”

Did drug companies spend $10 billion on consumer advertising in 2024, making up nearly 25% of evening ad minutes?

Reading Time: < 1 minute

Wisconsin Watch partners with Gigafact to produce fact briefs — bite-sized fact checks of trending claims. Read our methodology to learn how we check claims.

Yes.

Pharmaceutical companies spent over $10.1 billion on drug advertising in 2024 with the top 10 drugs accounting for a third of spending. Over $5 billion of the spending was on TV ads, with the other half spent on radio, print, streaming and online ads.  

The advertising for these pharmaceutical companies made up 24.4% of evening ad minutes on news programs through ABC, CBS, CNN, Fox News, MSNBC and NBC between Jan. 1 and May 31 of this year. 

Drug company AbbVie spent the most, totaling over $1 billion on ads for Skyrizi and Rinvoq, which are used to treat inflammatory conditions. AbbVie increased spending on advertisements for Skyrizi by 150%.

Between 2023 and 2024, consumer advertising of the weight management drug Wegovy increased 330%. During that period, usage among teens increased 50%.

The U.S. is one of only two countries that allow direct pharmaceutical advertising.

This fact brief is responsive to conversations such as this one.

Sources

Think you know the facts? Put your knowledge to the test. Take the Fact Brief quiz

Did drug companies spend $10 billion on consumer advertising in 2024, making up nearly 25% of evening ad minutes? is a post from Wisconsin Watch, a non-profit investigative news site covering Wisconsin since 2009. Please consider making a contribution to support our journalism.

❌